Castle Biosciences, Inc. (CSTL) DCF Valuation

Castle Biosciences, Inc. (CSTL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Castle Biosciences, Inc. (CSTL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Castle Biosciences, Inc. (CSTL) with our advanced DCF Calculator! Adjust critical assumptions, explore various scenarios, and evaluate how different changes affect the valuation of Castle Biosciences, Inc. (CSTL) – all within one convenient Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 51.9 62.6 94.1 137.0 219.8 317.0 457.3 659.7 951.7 1,372.8
Revenue Growth, % 0 20.79 50.18 45.65 60.38 44.25 44.25 44.25 44.25 44.25
EBITDA 7.7 -7.1 -36.6 -58.3 -45.0 -62.4 -90.1 -129.9 -187.4 -270.4
EBITDA, % 14.82 -11.32 -38.91 -42.57 -20.49 -19.69 -19.69 -19.69 -19.69 -19.69
Depreciation .4 .5 3.4 10.5 12.3 11.6 16.8 24.2 35.0 50.4
Depreciation, % 0.69025 0.7534 3.62 7.69 5.61 3.67 3.67 3.67 3.67 3.67
EBIT 7.3 -7.6 -40.0 -68.9 -57.4 -74.1 -106.9 -154.2 -222.4 -320.8
EBIT, % 14.13 -12.08 -42.53 -50.27 -26.1 -23.37 -23.37 -23.37 -23.37 -23.37
Total Cash 98.8 409.9 329.6 258.6 243.1 317.0 457.3 659.7 951.7 1,372.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 14.6 12.8 17.3 23.5 38.3
Account Receivables, % 28.24 20.37 18.37 17.13 17.43
Inventories 1.2 2.2 2.0 4.0 7.9 9.3 13.3 19.3 27.8 40.1
Inventories, % 2.39 3.54 2.15 2.9 3.61 2.92 2.92 2.92 2.92 2.92
Accounts Payable 1.9 2.1 2.5 4.7 10.3 11.3 16.3 23.5 33.8 48.8
Accounts Payable, % 3.6 3.35 2.71 3.45 4.67 3.55 3.55 3.55 3.55 3.55
Capital Expenditure -.9 -4.8 -3.5 -5.6 -13.6 -14.8 -21.4 -30.9 -44.5 -64.2
Capital Expenditure, % -1.81 -7.58 -3.7 -4.11 -6.2 -4.68 -4.68 -4.68 -4.68 -4.68
Tax Rate, % -0.17607 -0.17607 -0.17607 -0.17607 -0.17607 -0.17607 -0.17607 -0.17607 -0.17607 -0.17607
EBITAT 7.2 -7.6 -31.3 -67.1 -57.5 -70.3 -101.4 -146.2 -211.0 -304.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.4 -10.8 -35.2 -68.2 -72.0 -99.9 -133.6 -192.7 -278.0 -401.0
WACC, % 9 9 8.98 9 9 9 9 9 9 9
PV UFCF
SUM PV UFCF -810.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -409
Terminal Value -5,845
Present Terminal Value -3,799
Enterprise Value -4,610
Net Debt -84
Equity Value -4,526
Diluted Shares Outstanding, MM 27
Equity Value Per Share -168.87

What You Will Get

  • Real CSTL Financial Data: Pre-filled with Castle Biosciences' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Castle Biosciences' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life CSTL Financials: Pre-filled historical and projected data for Castle Biosciences, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Castle Biosciences’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Castle Biosciences’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Castle Biosciences, Inc. (CSTL) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Castle Biosciences, Inc. (CSTL)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Castle Biosciences, Inc. (CSTL)?

  • Accurate Data: Up-to-date Castle Biosciences financials provide trustworthy valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Ready-to-use calculations save you from starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and guided instructions make it accessible for all users.

Who Should Use This Product?

  • Investors: Evaluate Castle Biosciences’ valuation before making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and validate financial forecasts.
  • Startup Founders: Understand how biotech companies like Castle Biosciences are appraised.
  • Consultants: Provide expert valuation analyses and reports for clients in the healthcare sector.
  • Students and Educators: Utilize real-life data to learn and teach valuation principles in biotechnology.

What the Template Contains

  • Pre-Filled DCF Model: Castle Biosciences’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Castle Biosciences’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.